Loxo Oncology Inc.
Compounds useful as kinase inhibitors

Last updated:

Abstract:

This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

Status:
Grant
Type:

Utility

Filling date:

27 Aug 2018

Issue date:

5 Nov 2019